Progress in the treatment of Friedreich ataxia
- PMID: 29499876
- DOI: 10.1016/j.pjnns.2018.02.003
Progress in the treatment of Friedreich ataxia
Abstract
Friedreich ataxia (FRDA) is a progressive neurological disorder affecting approximately 1 in 29,000 individuals of European descent. At present, there is no approved pharmacological treatment for this condition however research into treatment of FRDA has advanced considerably over the last two decades since the genetic cause was identified. Current proposed treatment strategies include decreasing oxidative stress, increasing cellular frataxin, improving mitochondrial function as well as modulating frataxin controlled metabolic pathways. Genetic and cell based therapies also hold great promise. Finally, physical therapies are being explored as a means of maximising function in those affected by FRDA.
Keywords: Friedreich ataxia; Gene therapy; Rehabilitation; Therapy.
Copyright © 2018 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical